BackGilead Sciences Overview

Gilead Sciences Intangible Assets

Gilead Sciences's intangible assets is $14B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$14.03B
24.43% YoYΔ $-4.54B vs prior year quarter

Peer trimmed avg / median

Loading

Gilead Sciences Intangible Assets History

Loading

Gilead Sciences vs. peers: Intangible Assets Comparison

Loading

Gilead Sciences Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gilead Sciences (GILD) FAQ

As of the most recent data (June 2026), GILD shows a intangible assets of $14B. That compares with $19B in the prior-year period — down 24.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GILD's intangible assets is now $14B (was $19B) — a 24.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Gilead Sciences is outperforming or lagging.

Tracking GILD's intangible assets over time shows whether Gilead Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $14B That compares with $19B in the prior-year period — down 24.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Gilead Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $14B) with ownership activity and broader fundamentals.

Gilead Sciences's intangible assets is $14B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.